Advances in Alzheimer’s disease’s pharmacological treatment

Alzheimer’s disease (AD) is the most common type of dementia in the elderly. Several hypotheses emerged from AD pathophysiological mechanisms. However, no neuronal protective or regenerative drug is available nowadays. Researchers still work in drug development and are finding new molecular targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Conti Filho, Carlos Elias, Loss, Lairane Bridi, Marcolongo-Pereira, Clairton, Rossoni Junior, Joamyr Victor, Barcelos, Rafael Mazioli, Chiarelli-Neto, Orlando, da Silva, Bruno Spalenza, Passamani Ambrosio, Roberta, Castro, Fernanda Cristina de Abreu Quintela, Teixeira, Sarah Fernandes, Mezzomo, Nathana Jamille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933512/
https://www.ncbi.nlm.nih.gov/pubmed/36817126
http://dx.doi.org/10.3389/fphar.2023.1101452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933512/
https://www.ncbi.nlm.nih.gov/pubmed/36817126
http://dx.doi.org/10.3389/fphar.2023.1101452

Ejemplares similares